Comparison of Neoadjuvant Chemotherapy, Chemoimmunotherapy, and Upfront Radical Cystectomy in High-Risk Bladder Cancer: A Single-Center Retrospective Study

Shaohua Chen, Xiao Gan, Ping Lv, Qinggui Meng, Xiaocao Lin, Qingyun Zhang · 2026

Read Comparison of Neoadjuvant Chemotherapy, Chemoimmunotherapy, and Upfront Radical Cystectomy in High-Risk Bladder Cancer: A Single-Center Retrospective Study by Shaohua Chen, Xiao Gan, Ping Lv, Qinggui Meng, Xiaocao Lin, Qingyun Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13591363.txt.

Description

Shaohua Chen and co-authors compare three paths to bladder cancer surgery at one hospital, in a 2026 study. Removing the bladder is standard for cancer that invades the muscle wall. Tiny spread beyond the bladder drives many relapses. Drug therapy before surgery offers modest gains, and immune drugs add a new option.

The study reviewed 80 patients who had the surgery. About two thirds had no drug therapy first, and the rest had chemotherapy with or without immune drugs. Survival curves and tissue responses were compared across the groups. The team also hunted for markers that predict who responds to the drugs. Real-world comparisons of this kind help weigh new combinations before large trials report.

Catalog record

CREATORShaohua Chen, Xiao Gan, Ping Lv, Qinggui Meng, Xiaocao Lin, Qingyun Zhang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13591363

Browse the full library · About the Tower of Babel